Matrix

[whytestocks]

JUST IN: $ORTX Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy(TM) for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)

First therapy recommended for full marketing authorization in the EU for eligible patients with confirmed diagnosis of late infantile or early juvenile MLD variants One-time treatment with Libmeldy has been shown to preserve cognitive and motor function in most patients ...

In case you are interested ORTX - Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy(TM) for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)